RRM2 and neoplasm: m6A-modulated mRNA stability, particularly via IGF2BP1, regulates the expression of RRM2 and thrombospondin 1 (THBS1), contributing to resistance against ferroptosis and the glycolytic reprogramming of tumor-associated macrophages, ultimately promoting tumor progression and fibrosis.49